Apellis (APLS) Stock Up 50% in Three Months: Here's Why?

Published on 11 Apr 2023 on Zacks via Yahoo Finance

Apellis’ APLS shares have rallied almost 50% in the past three months against the industry's 5.3% decline.

Zacks Investment Research

Image Source: Zacks Investment Research

Read the rest of the article

Start tracking your investments with Statfolio

KALA BIO (KALA) delivered earnings and revenue surprises of -58.60% and 100%, respectively, for t...

Zacks · via Yahoo Finance 16 Nov 2023

In this piece, we will take a look at the ten best stocks to buy for a quick return. For more sto...

Insider Monkey via Yahoo Finance 11 May 2023

Madrigal Pharmaceuticals' MDGL shares were up almost 13% on Apr 18, as its pipeline candidate, re...

Zacks via Yahoo Finance 19 Apr 2023

The biotech sector has been in focus in the past week with key pipeline and regulatory updates. A...

Zacks via Yahoo Finance 19 Apr 2023

Humanigen HGEN stock was up almost 20% on Apr 14, as it presented the baseline results of its Pre...

Zacks via Yahoo Finance 17 Apr 2023

Kala Pharmaceuticals, Inc. KALA, a clinical-stage biopharmaceutical company’s shares were up 2.52...

Zacks via Yahoo Finance 12 Apr 2023

Panbela Therapeutics PBLA, a clinical stage biopharmaceutical company, gained almost 37.5% in pre...

Zacks via Yahoo Finance 12 Apr 2023

Apellis’ APLS shares have rallied almost 50% in the past three months against the industry's 5.3%...

Zacks via Yahoo Finance 11 Apr 2023

In this piece, we will take a look at the ten eyecare stocks with upside potential. For more stoc...

Insider Monkey via Yahoo Finance 5 Apr 2023

KodiakSciences KOD announced that the first patient has been treated in the early-stage study of ...

Zacks via Yahoo Finance 4 Apr 2023